Home/Filings/4/0001209191-21-004265
4//SEC Filing

Grossman William 4

Accession 0001209191-21-004265

CIK 0001724521other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:11 PM ET

Size

7.2 KB

Accession

0001209191-21-004265

Insider Transaction Report

Form 4
Period: 2021-01-19
Grossman William
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-01-19+18,75025,477 total
  • Award

    Stock Option (right to buy)

    2021-01-19+112,500112,500 total
    Exercise: $36.73Exp: 2031-01-18Common Stock (112,500 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in four equal annual installments after January 1, 2021, subject to the Reporting Person's continued service to the Company.
  • [F2]The option is exercisable in 48 equal monthly installments after January 1, 2021, subject to the Reporting Person's continued service to the Company.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001730229

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:11 PM ET
Size
7.2 KB